NITROCONTIN

This brand name is authorized in Nigeria.

Active ingredients

The drug NITROCONTIN contains one active pharmaceutical ingredient (API):

1
UNII G59M7S0WS3 - NITROGLYCERIN
 

Glyceryl trinitrate is a vasodilator and is used for angina of effort. Vasodilation is achieved by the releasing of free redical nitric oxide which activates guanylate cyclase and increases synthesis of guanosine 3′ and 5′-monophosphate with resultant effects on the phosphorylation of proteins in smooth muscle. If taken in excess, its vasodilatory effect can cause headache.

 
Read more about Glyceryl trinitrate

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-7838 Tablet NITROCONTIN 2.6 TAB 2,6mg 125 NITROCONTIN 2.6 DILUTED NITROGLYCERIN DILUTED NITROGLYCERIN 2.6,HYDROXYETHYL CELLULOSE,CETOSTEARLY ALCOHOL,,MAGNESUIM STEARTE A4-7838 Drugs Imported Products 125 Prescription Only Medicine (POM) 24/10/2022 PHILLIPS PHARMACEUTICALS (NIGERIA) LTD, APAPA-OSHODI EXPRESSWAY, IYANA-ISOLO LAGOS LAGOS 8035493198 samson.omattah@phillipsnigeria.com MODI MUNDI PHARMA PVT LTD, MODIPURAM 250110 UP INDIA MEERUT MUZAFAAR NAGAR RD , India 26/04/2023
A4-7839 Tablet NITROCONTIN 6.4 TAB 6.4mg 125 NITROCONTIN 6.4 NITROGLYCERIN Nitroglycerin Diluted (10%).1. Lactose 2. Hydroxyethyl Cellulose 3. Cetostearyl alcohol 4. Carbomer Homopolymer 5. Purified Talc 6. Magnesium Stearate 7. Erythrosine Lake 8. Purified Water A4-7839 Drugs Imported Products 125 POM 1 24/10/2022 PHILLIPS PHARMACEUTICALS (NIGERIA) LIMITED, PLOT 122-123 AFRIPRINT ESTATE, ISOLO 8035493198 samson.omattah@phillipsnigeria.com MODI MUNDI PHARMA PVT LTD, MODIPURAM 250110 UP INDIA MEERUT MUZAFAAR NAGAR RD , India 31/08/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C01DA02 Glyceryl trinitrate C Cardiovascular system → C01 Cardiac therapy → C01D Vasodilators used in cardiac diseases → C01DA Organic nitrates
Discover more medicines within C01DA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-7838, A4-7839

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.